Blue Safari Group Acquisition Corp - Class A

BSGA 4 | $10.0 19.76% 22.5% 0

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (19.8% 3d) (0.0% 7d) (51.06% volume)
Earnings Calendar:
Market Cap:

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Icosavax Inc

ICVX | $15.31 -0.65% 9.3M

(0.0% 1d) (0.0% 1m) (178.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (90.69% volume)
Earnings Calendar: 2023-08-14
Market Cap: $ 766,883,121
https://icosavax.com
Sec Filling | Patents | 2021 employees

Icosavax is a biopharmaceutical company leveraging its innovative VLP platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases. Icosavax’s VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, which it believes will induce broad, robust, and durable protection against the specific viruses targeted. Icosavax’s pipeline includes vaccine candidates targeting respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Icosavax was formed in 2017 to advance the breakthrough VLP technology from the Institute for Protein Design at the University of Washington with the goal to discover, develop, and commercialize vaccines against infectious diseases. Icosavax exclusively licensed the VLP technology for use in several fields, including RSV and hMPV, from the University of Washington. For SARS-CoV-2, Icosavax has a non-exclusive, worldwide (excluding South Korea) license from the University of Washington that will convert to an exclusive license in North America and Europe in 2025. Icosavax is located in Seattle.

vaccine rsv respiratory diseases respiratory

add to watch list Paper trade email alert is off

Mountain Crest Acquisition Corp IV

MCAF | $14.85 -59.6% 29K

(0.0% 1d) (32.7% 1m) (43.6% 1y) (0.0% 2d) (10.1% 3d) (0.0% 7d) (-49.7% volume)
Earnings Calendar:
Market Cap: $ 49,220,191

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Rallybio Corp

RLYB | News | $1.615 -7.18% 190K

(0.0% 1d) (20.3% 1m) (-64.2% 1y) (0.0% 2d) (2.0% 3d) (5.6% 7d) (NaN% volume)
Earnings Calendar: 2024-03-04
Market Cap: $ 61,066,332
https://rallybio.com
Sec Filling | Patents | 2021 employees

Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut, with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut.

urea metabolic

add to watch list Paper trade email alert is off

RxSight Inc

RXST | News | $53.87 -1.91% 140K

(0.0% 1d) (12.1% 1m) (216.2% 1y) (0.0% 2d) (4.9% 3d) (6.5% 7d) (27.08% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 1,992,519,642

Sec Filling | Patents | 2021 employees

calhoun vision is the world leader in adjustable intraocular lens technology. the company's proprietary technology utilizes light to enable surgeons to change the power of a lens after it has been implanted in the eye. this offers the potential to provide unparalleled visual outcomes and customization to the specific visual needs of each patient. calhoun vision's light adjustable lens technology is an investigational device in the united states and requires fda approval before it can be marketed commercially. the company has completed phases i and ii of the required clinical investigation; the third and final phase of study has commenced, and all subjects have been fully enrolled.

add to watch list Paper trade email alert is off

Omega Therapeutics Inc

OMGA | $2.33 -0.43% 130K

(0.0% 1d) (-31.4% 1m) (-67.5% 1y) (0.0% 2d) (-6.0% 3d) (-2.5% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 128,511,115

Sec Filling | Patents | 2021 employees

omega therapeutics™ is a preclinical stage genomic medicine enterprise transforming medicine and patient care through precision genomic control. the company’s platform is focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences. we are developing precision therapeutics for a range of disease indications including rare genetic diseases, immunology, inflammation, metabolic diseases and oncology. # transformativemedicines #pioneeringmedicines

add to watch list Paper trade email alert is off

TGPX Holdings I LLC

COOK 4 | $2.11 -1.4% 120K

(0.0% 1d) (-13.4% 1m) (-29.8% 1y) (0.0% 2d) (3.4% 3d) (1.4% 7d) (152.59% volume)
Earnings Calendar:
Market Cap: $ 269,955,001
https://www.traegergrills.com
Sec Filling | Patents | 2021 employees

Traeger Grills, headquartered in Salt Lake City, is the creator and category leader of the wood pellet grill, a versatile and easy to use outdoor cooking system. Traeger pellet grills use all-natural hardwood fuel to infuse food with flavorful smoke, making food taste delicious and most of all, memorable. Traeger pellet grills utilize wood-fired convection power to provide 6-in-1 versatility; owners can grill, smoke, bake, roast, braise and barbecue meals on one cooking system.

food

add to watch list Paper trade email alert is off

Project Angel Parent LLC

MLNK 4 | $17.64 -2.0% 110K

(0.0% 1d) (0.1% 1m) (21.1% 1y) (0.0% 2d) (1.6% 3d) (4.6% 7d) (55.68% volume)
Earnings Calendar:
Market Cap: $ 1,349,212,105
https://www.meridianlink.com
Sec Filling | Patents | 472 employees

(US) MeridianLink has remained at the center of the financial institution ecosystem with cloud-based software solutions for more than 20 years. The company supports the digital transformation of financial institutions with its mission-critical software.

add to watch list Paper trade email alert is off

Nuvalent Inc - Class A

NUVL | $67.91 0.46% 290K

(0.0% 1d) (-11.6% 1m) (91.5% 1y) (0.0% 2d) (4.8% 3d) (7.7% 7d) (6.71% volume)
Earnings Calendar: 2023-08-09
Market Cap: $ 3,981,725,197
https://www.nuvalent.com
Sec Filling | Patents | 2021 employees

Nuvalent, Inc. is a preclinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, Nuvalent develops innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.

cancer

add to watch list Paper trade email alert is off

Worksport Ltd

WKSP | $0.38 3.8% 110K

Manufacturing

(0.0% 1d) (-38.2% 1m) (-78.7% 1y) (0.0% 2d) (0.0% 3d) (-5.1% 7d) (-16.4% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 9,158,157
https://worksport.com
Sec Filling | Patents | 4 employees

Worksport Ltd. designs and distributes pickup truck covers called tonneau covers throughout the United States and Canada. The firm assists businesses by acquiring investment capital for continued growth and expansion while providing business development and marketing strategies, and offers its services in the United States and Canada. The company was founded on April 2, 2003 and is headquartered in Vaughan, Canada.

add to watch list Paper trade email alert is off

SharpLink Gaming Ltd

SBET | $1.2099 540

Manufacturing

(0.0% 1d) (-17.7% 1m) (-62.9% 1y) (0.0% 2d) (1.7% 3d) (1.7% 7d) (161.76% volume)
Earnings Calendar:
Market Cap: $ 3,976,467
https://www.mtsint.com
Sec Filling | Patents | 24 employees

(IL) Mer Telemanagement Solutions Ltd. is focused on innovative products and services for enterprises in the area of telecom expense management ("TEM") and Call Accounting. Headquartered in Israel, MTS markets its solutions through wholly-owned subsidiaries in Israel, the U.S and Hong Kong, as well as through distribution channels.

urea israel

add to watch list Paper trade email alert is off

Immuneering Corp Class A

IMRX | $1.5 -7.98% 400K

(0.0% 1d) (-35.6% 1m) (-83.9% 1y) (0.0% 2d) (-5.2% 3d) (-9.4% 7d) (-0.11% volume)
Earnings Calendar: 2024-03-04
Market Cap: $ 43,924,908

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off